who is developing retatrutide Makes Retatrutide? Company Behind the Weight Loss Drug Retatrutide for weight loss: Study

Every expert agrees that the most common side effects of GLP-1s are constipation

GLP-1 (Glucagon-like Peptide-1) is a natural incretin hormone that: Stimulates insulin secretion (when glucose is high) Suppresses glucagon release Slows gastric emptying Increases satiety reducing food intake Why GLP-1 Therapy Stands Out Glycemic Control Lowers HbA1c by ~11.5% with minimal hypoglycemia risk Weight Loss 515 kg depending on drug/dose (semaglutide leads the way) Cardiovascular Protection Reduced major CV events (MACE) in trials like LEADER, SUSTAIN, REWIND Renal Protection Slows progression of diabetic kidney disease Convenience Available as daily or weekly injections and even oral semaglutide Key Clinical Trials LEADER (Liraglutide) CV mortality & MACE SUSTAIN-6 (Semaglutide) CV events & strong weight loss REWIND (Dulaglutide) CV protection even in lower-risk populations STEP Trials (Semaglutide) Double-digit weight reduction in obesity The Bigger Picture GLP-1 therapy goes beyond insulin and beyond diabetes

A novel GLP-1/xenin hybrid peptide improves glucose homeostasis, circulating lipids and restores GIP sensitivity in high fat fed mice

Pregnant woman Patient with cardiovascular problem * The result depends on individual metabolism

387:224557 doi: 10.1056/NEJMoa2208601 15 EMA

GLP-1 Medications Work Strongest After Injection GLP-1s are designed to slow digestion, curb cravings, and reduce appetite and those effects are most noticeable in the 12 days following your shot